Evidence map›Paper›PMID 15153335›Full record

ArticleNeoplasia (New York, N.Y.)

Urine telomerase: an important marker in the diagnosis of bladder cancer.

Maria Aurora Sanchini, Sara Bravaccini, Laura Medri, Roberta Gunelli, Oriana Nanni, Franco Monti, Paolo Carlo Baccarani, Alberto Ravaioli, Eduard Bercovich, Dino Amadori and 1 more

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Review
  3. Activating TelomeraseInternational journal of molecular sciences · 2020
    Review
  4. Article
  5. The current role of telomerase in the diagnosis of bladder cancer.Indian journal of urology : IJU : journal of the Urological Society of India · 2009
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Maria Aurora SanchiniDivision of Oncology and Diagnostics, Pierantoni Hospital, Forlì, Italy.
Sara Bravaccini
Laura Medri
Roberta Gunelli
Oriana Nanni
Franco Monti
Paolo Carlo Baccarani
Alberto Ravaioli
Eduard Bercovich
Dino Amadori
Daniele Calistri
Ospedale G.B. Morgagni - L.Pierantoni · ITOspedale Infermi di Rimini · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomerase activity is present in most human malignant tumors, whereas it is generally not detectable, with some exceptions, in normal cells. Therefore, it represents a potential tool for tumor detection. In the present study, telomerase activity was determined in urine from 79 healthy individuals and 121 previously untreated bladder cancer patients using a highly sensitive telomeric repeat amplification protocol (TRAP) assay and the results were expressed as arbitrary enzymatic units (AEU). This approach enabled us to identify cutoff values characterized by high sensitivity (from 75% to 93%) and specificity (from 72% to 92%). Moreover, analysis as a function of gender showed a higher accuracy of TRAP assay in males (93% sensitivity and 90% specificity at the cutoff of 50 AEU) than in females. This sensitivity was confirmed in patients with nonassessable or negative cytology. In women, morphological and immunocytochemical determinations using a monoclonal antibody (anti-hTERT) recently developed in our laboratory showed a large fraction of immunoreactive inflammatory or nonbladder cells, which may justify the false-positive TRAP results. In conclusion, this assay represents an important noninvasive diagnostic tool to detect bladder cancer also in patients with negative or nonassessable urine cytology and with low-grade and early-stage lesions.

Indexed as

Biomarkers, TumorDNA-Binding ProteinsFemaleHumansMaleSensitivity and SpecificityTelomeraseUrinary Bladder NeoplasmsBiomarkers, TumorDNA-Binding ProteinsTelomerase

Identifiers

PMID15153335
PMCPMC1502100
OpenAlexW2004199553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.